Clinical Trial Update: Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 induction and maintenance study of BMS-936557 in moderate to severely active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• BMS-936557

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED